These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9158187)

  • 1. Changing attitudes towards breast-conserving treatment of early breast cancer in the south-eastern Netherlands: results of a survey among surgeons and a registry-based analysis of patterns of care.
    Voogd AC; Repelaer van Driel OJ; Roumen RM; Crommelin MA; van Beek MW; Coebergh JW
    Eur J Surg Oncol; 1997 Apr; 23(2):134-8. PubMed ID: 9158187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Trends and variation in breast conserving surgery in the southeast and east of the Netherlands over the period 1990-2002].
    Siesling S; van de Poll-Franse LV; Jobsen JJ; Repelaer van Driel OJ; Voogd AC
    Ned Tijdschr Geneeskd; 2005 Aug; 149(35):1941-6. PubMed ID: 16159034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the investigation and management of primary operable breast cancer in Victoria.
    Hill DJ; White VM; Giles GG; Collins JP; Kitchen PR
    Med J Aust; 1994 Jul; 161(2):110-1, 114, 118 passim. PubMed ID: 8028535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical management of ductal carcinoma in situ in Australia in 1995.
    Shugg D; White VM; Kitchen PR; Pruden M; Collins JP; Hill DJ
    ANZ J Surg; 2002 Oct; 72(10):708-15. PubMed ID: 12534380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of breast-conserving therapy with mastectomy for treatment of early breast cancer in community hospitals.
    Voogd AC; Nab HW; Crommelin MA; van der Heijden LH; Kluck HM; Coebergh JW
    Eur J Surg Oncol; 1996 Feb; 22(1):13-6. PubMed ID: 8846859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and determinants of surgical management of screen detected breast cancer in the South-East Netherlands.
    Liebregts ME; van Riet YE; Nieuwenhuijzen GA; Rutten HJ; Duijm LE; Voogd AC
    Breast; 2013 Oct; 22(5):713-7. PubMed ID: 23352567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of microcalcifications that develop at the lumpectomy site after breast-conserving therapy.
    Vora SA; Wazer DE; Homer MJ
    Radiology; 1997 Jun; 203(3):667-71. PubMed ID: 9169686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast-conserving surgery for breast cancer: patterns of care in a geographic region and estimation of potential applicability.
    Foster RS; Farwell ME; Costanza MC
    Ann Surg Oncol; 1995 May; 2(3):275-80. PubMed ID: 7641025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma.
    Morrow M; White J; Moughan J; Owen J; Pajack T; Sylvester J; Wilson JF; Winchester D
    J Clin Oncol; 2001 Apr; 19(8):2254-62. PubMed ID: 11304779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of early-stage breast cancer in the Department of Defense Healthcare System.
    Kelemen JJ; Poulton T; Swartz MT; Jatoi I
    J Am Coll Surg; 2001 Mar; 192(3):293-7. PubMed ID: 11245370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of breast-conserving therapy for younger women with breast cancer.
    Guenther JM; Kirgan DM; Giuliano AE
    Arch Surg; 1996 Jun; 131(6):632-6. PubMed ID: 8645070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, 1990-2001.
    Siesling S; van de Poll-Franse LV; Jobsen JJ; Repelaer van Driel OJ; Voogd AC
    Breast; 2007 Dec; 16(6):606-14. PubMed ID: 17604628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast conservation therapy in affiliated county, university, and private hospitals.
    Heimbach JK; Biffl WL; Mitchell EL; Finlayson CA; Schwartzberg BS; Myers A; Rabinovitch R; Franciose RJ
    Am J Surg; 1999 Dec; 178(6):466-9. PubMed ID: 10670854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between findings on pre-treatment mammograms and local recurrence after breast-conserving therapy for invasive breast cancer.
    Voogd AC; van der Horst F; Crommelin MA; Peterse JL; van Beek MW; Repelaer van Driel OJ; van der Heijden LH; Coebergh JW
    Eur J Surg Oncol; 1999 Jun; 25(3):273-9. PubMed ID: 10336807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat breast-conserving treatment of ipsilateral breast cancer recurrence: a nationwide survey amongst breast surgeons and radiation oncologists in the Netherlands.
    Walstra CJEF; Schipper RJ; van Riet YE; van der Toorn PG; Smidt ML; Sangen MJCV; Voogd AC; Nieuwenhuijzen GAP
    Breast Cancer Res Treat; 2021 Jun; 187(2):499-514. PubMed ID: 33713244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST).
    Voogd AC; Peterse JL; Crommelin MA; Rutgers EJ; Botke G; Elkhuizen PH; van Geel AN; Hoekstra CJ; van Pel R; van de Vijver MJ; Coebergh JW
    Eur J Cancer; 1999 Dec; 35(13):1828-37. PubMed ID: 10673999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?
    Vrieling C; Collette L; Fourquet A; Hoogenraad WJ; Horiot JC; Jager JJ; Bing Oei S; Peterse HL; Pierart M; Poortmans PM; Struikmans H; Van den Bogaert W; Bartelink H;
    Eur J Cancer; 2003 May; 39(7):932-44. PubMed ID: 12706362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical contraindications are not a major factor in the underutilization of breast conserving therapy.
    Morrow M; Bucci C; Rademaker A
    J Am Coll Surg; 1998 Mar; 186(3):269-74. PubMed ID: 9510257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
    Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
    Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.